Skip to content

Contact Us: 1-518-583-0095    Follow Criterium on LinkedIn    We’re Hiring… Join Our Team!

Request a Proposal
Criterium
  • Home
  • Services
    • Clinical Trial Services
    • Client Services
    • IVR/IWR & ePRO
    • Criterium Technology
    • CORE Science Solutions
  • Oncology Consortia
    • Breast Cancer (ABRCC)
    • GI Cancer (AGICC)
    • Myeloma (AMyC)
    • Thoracic Oncology (ATOMIC)
    • Genitourinary Cancer (AURIC)
  • Therapeutic Areas
  • Resources
    • Case Studies
    • Publications & Abstracts
    • Videos & Podcasts
    • Whitepapers
    • Newsletter Archives
    • About Clinical Trials
  • News & Blog
  • About Us
    • The Criterium Edge
    • Executive Team
    • History
    • International Reach
  • Contact Us
    • Request a Proposal
    • Site Registration
    • Careers
  • Home
  • Services
    • Clinical Trial Services
    • Client Services
    • IVR/IWR & ePRO
    • Criterium Technology
    • CORE Science Solutions
  • Oncology Consortia
    • Breast Cancer (ABRCC)
    • GI Cancer (AGICC)
    • Myeloma (AMyC)
    • Thoracic Oncology (ATOMIC)
    • Genitourinary Cancer (AURIC)
  • Therapeutic Areas
  • Resources
    • Case Studies
    • Publications & Abstracts
    • Videos & Podcasts
    • Whitepapers
    • Newsletter Archives
    • About Clinical Trials
  • News & Blog
  • About Us
    • The Criterium Edge
    • Executive Team
    • History
    • International Reach
  • Contact Us
    • Request a Proposal
    • Site Registration
    • Careers
×

Category: AGICC

  1. Home
  2. AGICC

AGICC Investigator’s Meeting – Investigators Meet at ASCO GI For the First Time Since Covid

AGICC (Academic GI Cancer Consortium) met in person for an Investigator’s Meeting during the recent GI-ASCO 2023 Symposium in San Francisco. This coming year the AGICC group will continue to explore GI oncology trials in partnership with pharmaceutical companies. 

Continue reading

PharmaVoice Interview with Dr. Wells Messersmith, Director of the Academic GI Cancer Consortium (AGICC)

Watch the PharmaVoice One on One video interview below to learn more about the latest in Gastrointestinal Cancer research from Dr. Wells Messersmith, Director of the Academic GI Cancer Consortium and Division Head of Medical Oncology at the University of Colorado Cancer Center.

Continue reading

Recent Posts

  • ATOMIC Investigators Meeting – Investigators Meet at IASLC For the First Time Since Covid
  • Industry News: Medical Reports Positive One-year Results for PADN-CFDA Trial in Pulmonary Arterial Hypertension (PAH) Treatment English
  • AGICC Investigator’s Meeting – Investigators Meet at ASCO GI For the First Time Since Covid
  • AURIC Investigator’s Meeting – Successful First Meeting of Newly Formed Group
  • Industry News: Center for Breakthrough Medicines Launches Precision Plasmids™ Manufacturing to Accelerate Advanced Therapies into the Clinic

Get to Know Us!

Request a Proposal

Contact Us

Careers

Criterium Headquarters
358 Broadway, Suite 201
Saratoga Springs, NY 12866

Phone: 1-518-583-0095
Fax: 1-518-583-0394

Follow Criterium on LinkedInFollow Us on LinkedIn

About Us

The Criterium Edge

Executive Team

History

International Reach

Services

Clinical Trial Services

Client Services

IVR/IWR & ePRO

Criterium Technology

CORE Science Solutions

Our Experience

Oncology Consortia

Therapeutic Areas

Privacy Policy    |   Sitemap   |   Clinical Site Registration   |   CRA Registration

© COPYRIGHT CRITERIUM, INC. 2023. ALL RIGHTS RESERVED.

Manage Cookie Consent
We use cookies to optimize our website.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View Preferences
{title} {title} {title}
Manage Cookie Consent
We use cookies to optimize our website.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View Preferences
{title} {title} {title}